SciSparc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SciSparc and other ETFs, options, and stocks.

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. 

CEO
Oz Adler
CEOOz Adler
Employees
2
Employees2
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2004
Founded2004
Employees
2
Employees2

SPRC Key Statistics

Market cap
1.30M
Market cap1.30M
Price-Earnings ratio
-1.25
Price-Earnings ratio-1.25
Dividend yield
Dividend yield
Average volume
1.86M
Average volume1.86M
High today
$2.67
High today$2.67
Low today
$2.34
Low today$2.34
Open price
$2.44
Open price$2.44
Volume
294.12K
Volume294.12K
52 Week high
$37.59
52 Week high$37.59
52 Week low
$2.33
52 Week low$2.33

SPRC News

TipRanks 4d
SciSparc Ltd. Converts Debentures into Equity, Issuing New Shares

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 5d
SciSparc says AutoMax shareholders approve merger

SciSparc (SPRC)announced that AutoMax Motors convened its special general meetings, at which, among others, AutoMax’s shareholders voted on and approved the pro...

People also own

Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.